Comments On The Management Of Procured Organs From August 3, 2022 Capital Hill Hearing
Welcome to NephU’s Hot Topics in Nephrology Series featuring various experts in the field of nephrology. In this podcast series, thought leaders will share their expertise and perspectives on the latest developments and trends in the nephrology space.
In this episode, NephU hosts veteran nephrology editor Mark Neumann to discuss some of the updates from a recent hearing on Capital Hill regarding the bipartisan investigation into the United Network of Organ Sharing (UNOS). Thecommittee shared their concerns with UNOS’s oversight of the U.S. Organ Procurement and Transplantation Network (OPTN), specifically concerning its policy compliance and patient safety activities related to organ procurement organizations (OPOs).
Healthcare Writer & Editor
Specializing in Nephrology*
Mark Neumann started his career as a healthcare writer and editor in 1984 and has been covering clinical, regulatory, and economic issues in the kidney care field for the past 30 years. He is a previous winner of the President’s Award from the National Association of Nephrology Technicians and Technologists and a Medal of Excellence Award winner from the American Association of Kidney Patients.
Aaron Emmel, PharmD, MHA, BCPS
Nephrology Clinical & Scientific Director
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Aaron Emmel, PharmD, MHA, BCPS, joined Otsuka in 2018 and is currently a Senior Medical Science Liaison on our Nephrology South Team. Dr Emmel earned his Doctor in Pharmacy from the University of Florida in 2007 and his Masters in Health Administration from the University of North Florida in 2015. He has 10 years of experience as a clinical pharmacist, helping to develop and implement numerous clinical programs focused on ICU care, nutrition support, and antimicrobial stewardship. Additionally, he served as an administrator for a multi-specialty Clinically Integrated Network and ACO, helping to develop a Population Health Management strategy that included a coordinated approach to managing Chronic Kidney Disease. He has served as an Associate Clinical Professor for the University of Florida College of Pharmacy, delivering lectures and precepting students on Advanced Pharmacy Practice Experience rotations. Dr Emmel is Board Certified as a Pharmacotherapy Specialist by the Board of Pharmacy Specialties.
*Mark Neumann is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Aaron Emmel is an employee of OPDC.
Disclaimer: The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional.